Compounds > ketamine
Page last updated: 2024-10-29

ketamine and Deficiency Disease, Ornithine Carbamoyltransferase

ketamine has been researched along with Deficiency Disease, Ornithine Carbamoyltransferase in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, J2
Schroth, M2
Irouschek, A2
Birkholz, T2
Kurzai, M1
Kröber, S1
Meisner, M1
Albrecht, S2
Kroeber, S1

Other Studies

2 other studies available for ketamine and Deficiency Disease, Ornithine Carbamoyltransferase

ArticleYear
[Patients with ornithine transcarbamylase deficiency. Anaesthesiological and intensive care management].
    Der Anaesthesist, 2005, Volume: 54, Issue:12

    Topics: Adjuvants, Anesthesia; Adolescent; Anesthesia; Anesthesia, General; Anesthetics, Dissociative; Anest

2005
Anesthetic management of patients with ornithine transcarbamylase deficiency.
    Paediatric anaesthesia, 2006, Volume: 16, Issue:3

    Topics: Anesthesia, General; Anesthetics, Combined; Catheterization, Central Venous; Catheters, Indwelling;

2006